Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients

Fig. 2

Clinical and molecular characteristics of NSCLC patients associated with stemness index (mRNAsi). A Violin plot showing mRNAsi differences in different clinical feature groupings. B Relationship between mRNAsi and different feature groupings in NSCLC patient samples grouped by TMB height, and PTEN, TP53, EGFR, BRAF mutation status. *Indicates P value < 0.05,**indicates P value < 0.01, ***indicates P value < 0.001, ****indicates P value < 0.0001. C PFS survival analysis, red line represents high mRNAsi group, green line represents low mRNAsi group. D Differential enrichment pathways between the two groups of high and low mRNAsi are shown, each small box represents each patient’s enrichment score, with color changes indicating high or low scores: red for high scores and blue for low scores. The grouping of each patient is shown at the top of the heat map

Back to article page